Paper810077
Susceptibilities of gram-negative bacteria to combinations of antimicrobial agents in vitro.
Leng B and 3 others. Antimicrob Agents Chemother, 1975. Cited by 17 papers, by iCite.
Cite this record
ConductScience Library. Susceptibilities of gram-negative bacteria to combinations of antimicrobial agents in vitro. Papers, record 810077. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/810077
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Susceptibilities of gram-negative bacteria to combinations of antimicrobial agents in vitro.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anti-Bacterial Agents | Major topic |
| Enterobacteriaceae | Major topic |
| Drug Combinations | |
| Drug Therapy, Combination | |
| Enterobacteriaceae Infections | |
| Pseudomonas Infections | |
| Pseudomonas aeruginosa |
Source PubMed
References16
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 15825309 | Interaction of clindamycin and gentamicin in vitro. | Antimicrob Agents Chemother | 1974 | https://conductscience.org/library/papers/15825309 | PubMed |
| 2 | 5853047 | Gram-negative rod bacteremia. An analysis of 100 patients. | Am J Med | 1965 | https://conductscience.org/library/papers/5853047 | PubMed |
| 4 | 4326438 | In vitro activity of gentamicin, alone and in combination with other antibiotics. | Acta Pathol Microbiol Scand B Microbiol Immunol | 1971 | https://conductscience.org/library/papers/4326438 | PubMed |
| 5 | 4306976 | Gram-negative rod bacteremia. | J Infect Dis | 1969 | https://conductscience.org/library/papers/4306976 | PubMed |
| 6 | 4212049 | Hematologic malignancies and other marrow failure states: progress in the management of complicating infections. | Semin Hematol | 1974 | https://conductscience.org/library/papers/4212049 | PubMed |
| 7 | 4626620 | Tobramycin: in vitro antibacterial spectrum of a new aminoglycoside. | J Clin Pharmacol New Drugs | 1972 | https://conductscience.org/library/papers/4626620 | PubMed |
| 8 | 4579141 | In vivo antagonism between gentamicin and chloramphenicol in neutropenic mice. | J Infect Dis | 1973 | https://conductscience.org/library/papers/4579141 | PubMed |
| 9 | 4576800 | Kinetics and mechanisms of action of drugs on microorganisms. XVI. Effect of oleandomycin and its combinations with tetracycline, chloramphenicol, erythromycin, lincomycin, and 1'-demethyl-4'-depropyl-4'-(R and S)-n-pentylclindamycin on microbial generation of Escherichia coli. | J Pharm Sci | 1973 | https://conductscience.org/library/papers/4576800 | PubMed |
| 10 | 4550331 | Kinetics and mechanisms of drug action on microorganisms. 13. Comparative studies on action of lincomycin, clindamycin, and U 24729A against Escherichia coli. | J Med Chem | 1972 | https://conductscience.org/library/papers/4550331 | PubMed |
| 11 | 4961166 | [14C]erythromycin-ribosome complex formation and non-enzymatic binding of aminoacyl-transfer RNA to ribosome-messenger RNA complex. | Biochim Biophys Acta | 1966 | https://conductscience.org/library/papers/4961166 | PubMed |
| 12 | 4957605 | Binding of chloramphenicol to ribosomes. The effect of a number of antibiotics. | Biochim Biophys Acta | 1966 | https://conductscience.org/library/papers/4957605 | PubMed |
| 13 | 4923385 | Factors affecting mortality of gram-negative rod bacteremia. | Arch Intern Med | 1971 | https://conductscience.org/library/papers/4923385 | PubMed |
| 14 | 4871700 | The importance of underlying disease in patients with gram-negative bacteremia. | Arch Intern Med | 1968 | https://conductscience.org/library/papers/4871700 | PubMed |
| 15 | 4887382 | The comparative study on the effects of chloramphenicol, erythromycin and lincomycin on polylysine synthesis in an Escherichia coli cell-free system. | Biochim Biophys Acta | 1969 | https://conductscience.org/library/papers/4887382 | PubMed |
| 16 | 6061541 | Gram-negative septicemia: a growing threat. | Ann Surg | 1967 | https://conductscience.org/library/papers/6061541 | PubMed |
| 17 | 13822924 | Occurrence of serious bacterial infections since introduction of antibacterial agents. | J Am Med Assoc | 1959 | https://conductscience.org/library/papers/13822924 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 17 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 1329616 | Clindamycin, erythromycin, and roxithromycin inhibit the proinflammatory interactions of Pseudomonas aeruginosa pigments with human neutrophils in vitro. | Antimicrob Agents Chemother | 1992 | https://conductscience.org/library/papers/1329616 | PubMed |
| 817663 | Effect of clindamycin on the in vitro activity of amikacin and gentamicin against gram-negative bacilli. | Antimicrob Agents Chemother | 1976 | https://conductscience.org/library/papers/817663 | PubMed |
| 332070 | Bactericidal activity of the combinations of gentamicin with clindamycin or chloramphenicol against species of Escherichia coli and Bacteroides fragilis. | Antimicrob Agents Chemother | 1977 | https://conductscience.org/library/papers/332070 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/810077
GET https://conductscience.org/api/papers/v1/810077/authors